Helen Rubinstein | Director of Investor Relations |
Barry Greene | Chief Executive Officer |
Jim Doherty | Chief Development Officer |
Chris Benecchi | Chief Business Officer |
Kimi Iguchi | Chief Financial Officer |
Laura Gault | Chief Medical Officer |
Tazeen Ahmad | Bank of America |
Salveen Richter | Goldman Sachs |
Anupam Rama | JPMorgan |
Ritu Baral | Cowen |
Eason Lee | Needham |
Jay Olson | Oppenheimer |
Laura Chico | Wedbush Securities |
Sumant Kulkarni | Canaccord Genuity |
Yatin Suneja | Guggenheim |
Tim Lugo | William Blair |
Neena Bitritto-Garg | Citi |
Douglas Tsao | H.C. Wainwright |
Rudy Li | SVB Securities |
Gary Nachman | BMO Capital Markets |
Brian Abrahams | RBC Capital Markets |
Alex Nackenoff | Raymond James |
Joon Lee | Truist Securities |
Good morning. Welcome to the Sage Therapeutics' Fourth Quarter and Full-Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Sage's website at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction, or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited.